These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 29241370)
1. Identification of structural requirements and prediction of inhibitory activity of natural flavonoids against Zika virus through molecular docking and Monte Carlo based QSAR Simulation. Bhargava S; Patel T; Gaikwad R; Patil UK; Gayen S Nat Prod Res; 2019 Mar; 33(6):851-857. PubMed ID: 29241370 [TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo. Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942 [TBL] [Abstract][Full Text] [Related]
4. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through Yadav R; Selvaraj C; Aarthy M; Kumar P; Kumar A; Singh SK; Giri R J Biomol Struct Dyn; 2021 Jan; 39(1):272-284. PubMed ID: 31920173 [TBL] [Abstract][Full Text] [Related]
5. Monte Carlo method based QSAR modelling of natural lipase inhibitors using hybrid optimal descriptors. Kumar A; Chauhan S SAR QSAR Environ Res; 2017 Mar; 28(3):179-197. PubMed ID: 28271914 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus. Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship. Lim HJ; Nguyen TT; Kim NM; Park JS; Jang TS; Kim D Biotechnol Lett; 2017 Mar; 39(3):415-421. PubMed ID: 27885509 [TBL] [Abstract][Full Text] [Related]
8. Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization. Bhargava S; Adhikari N; Amin SA; Das K; Gayen S; Jha T SAR QSAR Environ Res; 2017 Dec; 28(12):973-990. PubMed ID: 29072112 [TBL] [Abstract][Full Text] [Related]
9. Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening. Bowen LR; Li DJ; Nola DT; Anderson MO; Heying M; Groves AT; Eagon S J Mol Model; 2019 Jun; 25(7):194. PubMed ID: 31209577 [TBL] [Abstract][Full Text] [Related]
10. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies. de Sousa LR; Wu H; Nebo L; Fernandes JB; da Silva MF; Kiefer W; Kanitz M; Bodem J; Diederich WE; Schirmeister T; Vieira PC Bioorg Med Chem; 2015 Feb; 23(3):466-70. PubMed ID: 25564380 [TBL] [Abstract][Full Text] [Related]
11. Structural basis of flavonoids as dengue polymerase inhibitors: insights from QSAR and docking studies. Anusuya S; Gromiha MM J Biomol Struct Dyn; 2019 Jan; 37(1):104-115. PubMed ID: 29254451 [TBL] [Abstract][Full Text] [Related]
12. The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors. Ghiasi T; Ahmadi S; Ahmadi E; Talei Bavil Olyai MR; Khodadadi Z SAR QSAR Environ Res; 2021 Jun; 32(6):495-520. PubMed ID: 34074200 [TBL] [Abstract][Full Text] [Related]
13. Development of prediction model for fructose- 1,6- bisphosphatase inhibitors using the Monte Carlo method. Manisha ; Chauhan S; Kumar P; Kumar A SAR QSAR Environ Res; 2019 Mar; 30(3):145-159. PubMed ID: 30777782 [TBL] [Abstract][Full Text] [Related]
14. The Application of the Combination of Monte Carlo Optimization Method based QSAR Modeling and Molecular Docking in Drug Design and Development. Zivkovic M; Zlatanovic M; Zlatanovic N; Golubović M; Veselinović AM Mini Rev Med Chem; 2020; 20(14):1389-1402. PubMed ID: 32048970 [TBL] [Abstract][Full Text] [Related]
15. In Silico Drug-Designing Studies on Flavanoids as Anticolon Cancer Agents: Pharmacophore Mapping, Molecular Docking, and Monte Carlo Method-Based QSAR Modeling. Simon L; Imane A; Srinivasan KK; Pathak L; Daoud I Interdiscip Sci; 2017 Sep; 9(3):445-458. PubMed ID: 27059855 [TBL] [Abstract][Full Text] [Related]
16. Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study. Jain S; Amin SA; Adhikari N; Jha T; Gayen S J Biomol Struct Dyn; 2020 Jan; 38(1):66-77. PubMed ID: 30646829 [TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors. Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854 [TBL] [Abstract][Full Text] [Related]
18. OpenZika: An IBM World Community Grid Project to Accelerate Zika Virus Drug Discovery. Ekins S; Perryman AL; Horta Andrade C PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005023. PubMed ID: 27764115 [TBL] [Abstract][Full Text] [Related]
19. Discovery of antiviral molecules for dengue: In silico search and biological evaluation. Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547 [TBL] [Abstract][Full Text] [Related]
20. Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor. Chan JF; Chik KK; Yuan S; Yip CC; Zhu Z; Tee KM; Tsang JO; Chan CC; Poon VK; Lu G; Zhang AJ; Lai KK; Chan KH; Kao RY; Yuen KY Antiviral Res; 2017 May; 141():29-37. PubMed ID: 28185815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]